Literature DB >> 33186707

A framework for patient-centered telemedicine: Application and lessons learned from vulnerable populations.

Andrew H Talal1, Elisavet M Sofikitou2, Urmo Jaanimägi1, Marija Zeremski3, Jonathan N Tobin4, Marianthi Markatou5.   

Abstract

Virtual technologies can facilitate clinical monitoring, clinician-patient interactions, and enhance patient-centered approaches to healthcare delivery. Telemedicine, two-way communication between a healthcare provider and a patient not in the same physical location, emphasizes patient preference and convenience by substituting the transportation of patients with information transfer. We present a framework for implementation of a comprehensive, dynamic, patient-centered telemedicine network deployed in 12 opioid treatment programs (OTP) located throughout New York State (NYS). The program aims to effectively manage hepatitis C virus (HCV) infection via telemedicine with co-administration of HCV and substance use medications. We have found that the Sociotechnical System model with emphasis on patient-centered factors provides a framework for telemedicine deployment and implementation to a vulnerable population. The issue of interoperability between the telemedicine platform and the electronic health record (EHR) system as well as clinical information retrieval for medical decision-making are challenges with implementation of a comprehensive, dynamic telemedicine system. Targeting telemedicine to a vulnerable population requires additional consideration of trust in the security and confidentiality of the telemedicine system. Our contribution is the valuable lessons learned from implementing a comprehensive, dynamic, patient-centered telemedicine system among an OTP network throughout NYS as applied to a vulnerable population that can be generalized to other difficult-to-reach populations.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Data quality and management; Design; Healthcare delivery system; Hepatitis C virus; Integrating substance use treatment into primary care; Telemedicine

Mesh:

Year:  2020        PMID: 33186707     DOI: 10.1016/j.jbi.2020.103622

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  6 in total

Review 1.  The Patient Perspective on Telemedicine.

Authors:  Karen Hoyt; Andrew Reynolds
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-28

2.  Psychometric properties of the Telepsych User Experience Scale (TUES).

Authors:  Brittany E Blanchard; Morgan Johnson; Matt Hawrilenko; Jared M Bechtel; Stephanie Shushan; John C Fortney
Journal:  J Rural Health       Date:  2021-12-27       Impact factor: 5.667

3.  Digitally Disconnected: Qualitative Study of Patient Perspectives on the Digital Divide and Potential Solutions.

Authors:  Maria Alcocer Alkureishi; Zi-Yi Choo; Ali Rahman; Kimberly Ho; Jonah Benning-Shorb; Gena Lenti; Itzel Velázquez Sánchez; Mengqi Zhu; Sachin D Shah; Wei Wei Lee
Journal:  JMIR Hum Factors       Date:  2021-12-15

4.  Kidney Care during COVID-19 in the UK: Perspectives of Healthcare Professionals on Impacts on Care Quality and Staff Well-Being.

Authors:  Archontissa Maria Kanavaki; Courtney Jane Lightfoot; Jared Palmer; Thomas James Wilkinson; Alice Caroline Smith; Ceri Rhiannon Jones
Journal:  Int J Environ Res Public Health       Date:  2021-12-24       Impact factor: 3.390

5.  Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.

Authors:  Shoshana V Aronowitz; Eden Engel-Rebitzer; Abby Dolan; Kehinde Oyekanmi; David Mandell; Zachary Meisel; Eugenia South; Margaret Lowenstein
Journal:  Harm Reduct J       Date:  2021-11-25

6.  A framework to support the progressive implementation of integrated team-based care for the management of COPD: a collective case study.

Authors:  Shannon L Sibbald; Vaidehi Misra; Madelyn daSilva; Christopher Licskai
Journal:  BMC Health Serv Res       Date:  2022-03-30       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.